These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Evaluation of E-Test for determination of antimicrobial MICs for Pseudomonas aeruginosa isolates from cystic fibrosis patients. Marley EF; Mohla C; Campos JM J Clin Microbiol; 1995 Dec; 33(12):3191-3. PubMed ID: 8586700 [TBL] [Abstract][Full Text] [Related]
5. Antimicrobial activity of tobramycin against respiratory cystic fibrosis Pseudomonas aeruginosa isolates from Bulgaria. Strateva T; Petrova G; Mitov I J Chemother; 2010 Dec; 22(6):378-83. PubMed ID: 21303744 [TBL] [Abstract][Full Text] [Related]
6. Mixed morphotype testing of Pseudomonas aeruginosa cultures from cystic fibrosis patients. Wolter JM; Kotsiou G; McCormack JG J Med Microbiol; 1995 Mar; 42(3):220-4. PubMed ID: 7884805 [TBL] [Abstract][Full Text] [Related]
7. Comparison of methods to test antibiotic combinations against heterogeneous populations of multiresistant Pseudomonas aeruginosa from patients with acute infective exacerbations in cystic fibrosis. Foweraker JE; Laughton CR; Brown DF; Bilton D Antimicrob Agents Chemother; 2009 Nov; 53(11):4809-15. PubMed ID: 19704123 [TBL] [Abstract][Full Text] [Related]
8. Phenotypic variability of Pseudomonas aeruginosa in sputa from patients with acute infective exacerbation of cystic fibrosis and its impact on the validity of antimicrobial susceptibility testing. Foweraker JE; Laughton CR; Brown DF; Bilton D J Antimicrob Chemother; 2005 Jun; 55(6):921-7. PubMed ID: 15883175 [TBL] [Abstract][Full Text] [Related]
9. Variable antibiotic susceptibility in populations of Pseudomonas aeruginosa infecting patients with bronchiectasis. Gillham MI; Sundaram S; Laughton CR; Haworth CS; Bilton D; Foweraker JE J Antimicrob Chemother; 2009 Apr; 63(4):728-32. PubMed ID: 19193658 [TBL] [Abstract][Full Text] [Related]
10. Standard versus biofilm antimicrobial susceptibility testing to guide antibiotic therapy in cystic fibrosis. Waters V; Ratjen F Cochrane Database Syst Rev; 2017 Oct; 10(10):CD009528. PubMed ID: 28981972 [TBL] [Abstract][Full Text] [Related]
11. Standard versus biofilm antimicrobial susceptibility testing to guide antibiotic therapy in cystic fibrosis. Waters V; Ratjen F Cochrane Database Syst Rev; 2015 Mar; (3):CD009528. PubMed ID: 25741986 [TBL] [Abstract][Full Text] [Related]
12. Bacteriological effects of anti-Pseudomonas aeruginosa chemotherapy in cystic fibrosis. Bauernfeind A; Emminger G; Hörl G; Ott S; Przyklenk B; Weisslein-Pfister C Infection; 1987; 15(5):403-6. PubMed ID: 3121519 [TBL] [Abstract][Full Text] [Related]
13. Pseudomonas aeruginosa from cystic fibrosis patients: study using whole cell RAPD and antibiotic susceptibility. Mereghetti L; Marquet-van der Mee N; Loulergue J; Rolland JC; Audurier A Pathol Biol (Paris); 1998 May; 46(5):319-24. PubMed ID: 9769892 [TBL] [Abstract][Full Text] [Related]
14. Standard versus biofilm antimicrobial susceptibility testing to guide antibiotic therapy in cystic fibrosis. Waters V; Ratjen F Cochrane Database Syst Rev; 2012 Nov; 11():CD009528. PubMed ID: 23152277 [TBL] [Abstract][Full Text] [Related]
15. Direct antimicrobial susceptibility testing method for analysis of sputum collected from patients with cystic fibrosis. Zebouh M; Thomas C; Honderlick P; Lemee L; Segonds C; Wallet F; Husson MO J Cyst Fibros; 2008 May; 7(3):238-43. PubMed ID: 18498727 [TBL] [Abstract][Full Text] [Related]
16. Comparison of the Micronaut Merlin automated broth microtiter system with the standard agar dilution method for antimicrobial susceptibility testing of mucoid and nonmucoid Pseudomonas aeruginosa isolates from cystic fibrosis patients. Balke B; Hoy L; Weissbrodt H; Häussler S Eur J Clin Microbiol Infect Dis; 2004 Oct; 23(10):765-71. PubMed ID: 15605183 [TBL] [Abstract][Full Text] [Related]
17. Evaluation of heteroresistance to polymyxin B among carbapenem-susceptible and -resistant Pseudomonas aeruginosa. Hermes DM; Pormann Pitt C; Lutz L; Teixeira AB; Ribeiro VB; Netto B; Martins AF; Zavascki AP; Barth AL J Med Microbiol; 2013 Aug; 62(Pt 8):1184-1189. PubMed ID: 23699064 [TBL] [Abstract][Full Text] [Related]
18. Susceptibility testing of Pseudomonas aeruginosa isolates and clinical response to parenteral antibiotic administration: lack of association in cystic fibrosis. Smith AL; Fiel SB; Mayer-Hamblett N; Ramsey B; Burns JL Chest; 2003 May; 123(5):1495-502. PubMed ID: 12740266 [TBL] [Abstract][Full Text] [Related]
19. Recovery of antimicrobial-resistant Pseudomonas aeruginosa from sputa of cystic fibrosis patients by culture on selective media. Perry JD; Laine L; Hughes S; Nicholson A; Galloway A; Gould FK J Antimicrob Chemother; 2008 May; 61(5):1057-61. PubMed ID: 18316821 [TBL] [Abstract][Full Text] [Related]
20. Combination antimicrobial susceptibility testing for acute exacerbations in chronic infection of Pseudomonas aeruginosa in cystic fibrosis. Smith S; Ratjen F; Remmington T; Waters V Cochrane Database Syst Rev; 2020 May; 5(5):CD006961. PubMed ID: 32412092 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]